| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Kronenfeld Mark A. is a Director at Pacira BioSciences, Inc.. Recent SEC Form 4 filings include 4 buys and 2 sells.
Estimated insider holdings value: $808K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 8, 2023 | PCRX Pacira Biosciences, Inc. | Director | Sale+OE | 15,000 | $37.04 | $555,600.00 | -45.6% | -5.7% | -22.8% | |
| Mar 6, 2019 | PCRX Pacira Biosciences, Inc. | Director | Buy | 1,700 | $38.97 | $66,244.00 | +9.5% | - | - | |
| Aug 28, 2018 | PCRX Pacira Biosciences, Inc. | Director | Buy | 1,000 | $44.61 | $44,611.20 | +13.2% | - | - | |
| Nov 10, 2017 | PCRX Pacira Biosciences, Inc. | Director | Buy | 1,000 | $41.60 | $41,602.50 | +17.3% | - | - | |
| Jun 6, 2016 | PCRX Pacira Biosciences, Inc. | Director | Sell | 900 | $46.95 | $42,255.00 | -23.4% | - | - |